Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Marisa Rose Nucci, M.D.

Co-Author

This page shows the publications co-authored by Marisa Nucci and Bradley Quade.
Connection Strength

2.459
  1. Chromosomal translocation t(8;12) induces aberrant HMGIC expression in aggressive angiomyxoma of the vulva. Genes Chromosomes Cancer. 2001 Oct; 32(2):172-6.
    View in: PubMed
    Score: 0.249
  2. h-Caldesmon expression effectively distinguishes endometrial stromal tumors from uterine smooth muscle tumors. Am J Surg Pathol. 2001 Apr; 25(4):455-63.
    View in: PubMed
    Score: 0.240
  3. Predictors of adverse outcome in uterine smooth muscle tumours of uncertain malignant potential (STUMP): a clinicopathological analysis of 22 cases with a proposal for the inclusion of additional histological parameters. Histopathology. 2018 Aug; 73(2):284-298.
    View in: PubMed
    Score: 0.197
  4. Involvement of Chromosome 8 in Müllerian Adenosarcoma. Int J Gynecol Pathol. 2017 Jan; 36(1):24-30.
    View in: PubMed
    Score: 0.179
  5. Myxoid Leiomyosarcoma of the Uterus: A Clinicopathologic Analysis of 30 Cases and Review of the Literature With Reappraisal of Its Distinction From Other Uterine Myxoid Mesenchymal Neoplasms. Am J Surg Pathol. 2016 Mar; 40(3):285-301.
    View in: PubMed
    Score: 0.169
  6. Inflammatory myofibroblastic tumor of the uterus: clinical and pathologic review of 10 cases including a subset with aggressive clinical course. Am J Surg Pathol. 2015 Feb; 39(2):157-68.
    View in: PubMed
    Score: 0.157
  7. Uterine polyps with features overlapping with those of Müllerian adenosarcoma: a clinicopathologic analysis of 29 cases emphasizing their likely benign nature. Am J Surg Pathol. 2015 Jan; 39(1):116-26.
    View in: PubMed
    Score: 0.156
  8. Targeted genomic analysis of Müllerian adenosarcoma. J Pathol. 2015 Jan; 235(1):37-49.
    View in: PubMed
    Score: 0.155
  9. Perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: clinicopathologic and immunohistochemical characterization of 16 cases. Am J Surg Pathol. 2014 Feb; 38(2):176-88.
    View in: PubMed
    Score: 0.146
  10. Targeted development of specific biomarkers of endometrial stromal cell differentiation using bioinformatics: the IFITM1 model. Mod Pathol. 2014 Apr; 27(4):569-79.
    View in: PubMed
    Score: 0.143
  11. Peritoneal dissemination complicating morcellation of uterine mesenchymal neoplasms. PLoS One. 2012; 7(11):e50058.
    View in: PubMed
    Score: 0.135
  12. Biomarkers in diagnostic obstetric and gynecologic pathology: a review. Adv Anat Pathol. 2003 Mar; 10(2):55-68.
    View in: PubMed
    Score: 0.069
  13. The role of CD10 staining in distinguishing invasive endometrial adenocarcinoma from adenocarcinoma involving adenomyosis. Mod Pathol. 2003 Jan; 16(1):22-7.
    View in: PubMed
    Score: 0.068
  14. Epithelioid Leiomyosarcoma of the Uterus: Modern Outcome-based Appraisal of Diagnostic Criteria in a Large Institutional Series. Am J Surg Pathol. 2021 Aug 23.
    View in: PubMed
    Score: 0.062
  15. Genomic Evolutionary Patterns of Leiomyosarcoma and Liposarcoma. Clin Cancer Res. 2019 08 15; 25(16):5135-5142.
    View in: PubMed
    Score: 0.053
  16. Assessment of a Chemotherapy Response Score (CRS) System for Tubo-Ovarian High-Grade Serous Carcinoma (HGSC). Int J Gynecol Pathol. 2019 May; 38(3):230-240.
    View in: PubMed
    Score: 0.053
  17. Clinicopathological and immunohistochemical features of uterine adenomyomatous polyps. Hum Pathol. 2019 02; 84:239-245.
    View in: PubMed
    Score: 0.051
  18. Abnormal p53 and p16 staining patterns distinguish uterine leiomyosarcoma from inflammatory myofibroblastic tumour. Histopathology. 2017 Jun; 70(7):1138-1146.
    View in: PubMed
    Score: 0.045
  19. Intravenous leiomyomatosis: an unusual intermediate between benign and malignant uterine smooth muscle tumors. Mod Pathol. 2016 05; 29(5):500-10.
    View in: PubMed
    Score: 0.042
  20. Risk Factors for Occult Uterine Sarcoma Among Women Undergoing Minimally Invasive Gynecologic Surgery. J Minim Invasive Gynecol. 2016 Jan; 23(1):34-9.
    View in: PubMed
    Score: 0.041
  21. The value of re-exploration in patients with inadvertently morcellated uterine sarcoma. Gynecol Oncol. 2014 Feb; 132(2):360-5.
    View in: PubMed
    Score: 0.036
  22. Identification of a basal/reserve cell immunophenotype in benign and neoplastic endometrium: a study with the p53 homologue p63. Gynecol Oncol. 2001 Jan; 80(1):30-6.
    View in: PubMed
    Score: 0.015
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.